Literature DB >> 20144965

Ocular side effects of anti-rheumatic medications: what a rheumatologist should know.

V Peponis1, V C Kyttaris, S E Chalkiadakis, S Bonovas, N M Sitaras.   

Abstract

Nearly every drug may cause changes to ocular tissues through a variety of mechanisms. Medication overdoses, drug-drug interactions but also chronic administration of medications at the recommended doses may lead to ocular toxicity. The ocular side effects, screening for eye toxicity and treatment guidelines for anti-inflammatory and immunosuppressive drugs commonly used by rheumatologists are reviewed herein.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20144965      PMCID: PMC2926651          DOI: 10.1177/0961203309360539

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  108 in total

1.  Hydroxychloroquine and visual screening in a rheumatology outpatient clinic.

Authors:  D J Grierson
Journal:  Ann Rheum Dis       Date:  1997-03       Impact factor: 19.103

2.  Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma.

Authors:  E Garbe; J LeLorier; J F Boivin; S Suissa
Journal:  JAMA       Date:  1997-03-05       Impact factor: 56.272

3.  Topical interferon alpha 2b for corneal haze after excimer laser photorefractive keratectomy. The Melbourne Excimer Laser Group.

Authors:  M C Gillies; S K Garrett; S M Shina; N Morlet; H R Taylor
Journal:  J Cataract Refract Surg       Date:  1996-09       Impact factor: 3.351

4.  Treatment of persistent glaucoma secondary to periocular corticosteroids.

Authors:  L Akduman; A E Kolker; D L Black; L V Del Priore; H J Kaplan
Journal:  Am J Ophthalmol       Date:  1996-08       Impact factor: 5.258

5.  Intraocular hemorrhage developing during interferon therapy.

Authors:  K Kuga; S Hasumura; S Nagamori; G Toda; K Kitahara
Journal:  Intern Med       Date:  1996-01       Impact factor: 1.271

6.  A randomized study comparing cyclosporine alone vs double and triple therapy in renal transplants. The Italian Multicentre Study Group for Renal Transplantation (SIMTRe).

Authors:  C Ponticelli; A Tarantino; G P Segoloni; V Cambi; G Rizzo; P Altieri; F Mastrangelo; M Castagneto; M Salvadori; U Valente; M Cossu; S Federico; F Pisani; G Montagnino; M Messina; L Arisi; M Carmellini; G Piredda; G Corbetta
Journal:  Transplant Proc       Date:  1997 Feb-Mar       Impact factor: 1.066

7.  Identification of a gene that causes primary open angle glaucoma.

Authors:  E M Stone; J H Fingert; W L Alward; T D Nguyen; J R Polansky; S L Sunden; D Nishimura; A F Clark; A Nystuen; B E Nichols; D A Mackey; R Ritch; J W Kalenak; E R Craven; V C Sheffield
Journal:  Science       Date:  1997-01-31       Impact factor: 47.728

Review 8.  Ocular toxicity and cancer chemotherapy. A review.

Authors:  T al-Tweigeri; J M Nabholtz; J R Mackey
Journal:  Cancer       Date:  1996-10-01       Impact factor: 6.860

9.  Retinal complications during interferon therapy for chronic hepatitis C.

Authors:  T Kawano; M Shigehira; H Uto; T Nakama; J Kato; K Hayashi; T Maruyama; T Kuribayashi; T Chuman; T Futami; H Tsubouchi
Journal:  Am J Gastroenterol       Date:  1996-02       Impact factor: 10.864

10.  Anterior ischemic optic neuropathy secondary to interferon alfa.

Authors:  V A Purvin
Journal:  Arch Ophthalmol       Date:  1995-08
View more
  13 in total

1.  Chloroquine improves the response to ischemic muscle injury and increases HMGB1 after arterial ligation.

Authors:  Jun Xu; Xiangdong Cui; Jiehua Li; Panagiotis Koutakis; Iraklis Pipinos; Edith Tzeng; Alex Chen; Ulka Sachdev
Journal:  J Vasc Surg       Date:  2017-03-01       Impact factor: 4.268

2.  Analysis of the prevalence of cataracts and glaucoma in systemic lupus erythematosus and evaluation of the rheumatologists' practice for the monitoring of glucocorticoid eye toxicity.

Authors:  L Carli; C Tani; F Querci; A Della Rossa; S Vagnani; C Baldini; R Talarico; A d'Ascanio; R Neri; A G Tavoni; S Bombardieri; M Mosca
Journal:  Clin Rheumatol       Date:  2013-03-03       Impact factor: 2.980

3.  Bilateral Transient Myopia with Sulfasalazine Treatment.

Authors:  Tal Paz; Daniel Rappoport; Assaf Hilely; Hana Leiba
Journal:  Clin Med Insights Case Rep       Date:  2019-06-18

4.  Antiarthritic Activity of Achyranthes Aspera on Formaldehyde - Induced Arthritis in Rats.

Authors:  Velmurugan Chinnasamy; Vetriselvan Subramaniyan; Sarath Chandiran; Saminathan Kayarohanam; Dhanapal Chidambaram Kanniyan; Venkata Sathya Saiappala Raju Velaga; Shafiulla Muhammad
Journal:  Open Access Maced J Med Sci       Date:  2019-08-30

5.  A Dose-Response Relationship of Alcohol Consumption with Risk of Visual Impairment in Korean Adults: The Kangbuk Samsung Health Study.

Authors:  So Young Han; Yoosoo Chang; Yejin Kim; Chul Young Choi; Seungho Ryu
Journal:  Nutrients       Date:  2022-02-14       Impact factor: 5.717

6.  Ophthalmic Combination of SurR9-C84A and Trichostatin-A Targeting Molecular Pathogenesis of Alkali Burn.

Authors:  Kislay Roy; Bhasker Sriramoju; Rupinder K Kanwar; Jagat R Kanwar
Journal:  Front Pharmacol       Date:  2016-07-28       Impact factor: 5.810

Review 7.  Hydroxychloroquine and the treatment of Sjogren syndrome, chronic ulcerative stomatitis, and oral lichen planus in the age of COVID-19.

Authors:  Heba Hussein; Ronald Brown
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2020-06-20

8.  Intra-Articular Formulation of GE11-PLGA Conjugate-Based NPs for Dexamethasone Selective Targeting-In Vitro Evaluation.

Authors:  Enrica Chiesa; Silvia Pisani; Barbara Colzani; Rossella Dorati; Bice Conti; Tiziana Modena; Kevin Braekmans; Ida Genta
Journal:  Int J Mol Sci       Date:  2018-08-06       Impact factor: 5.923

Review 9.  Ocular side effects of antirheumatic medications: a qualitative review.

Authors:  Clara M Castillejo Becerra; Yue Ding; Beatrice Kenol; Andrew Hendershot; Alexa Simon Meara
Journal:  BMJ Open Ophthalmol       Date:  2020-01-07

10.  Ocular Manifestations in Colombian Patients with Systemic Rheumatologic Diseases.

Authors:  Pilar Uribe-Reina; Juliana Muñoz-Ortiz; Carlos Cifuentes-González; Juliana Reyes-Guanes; Juan Pablo Terreros-Dorado; William Zambrano-Romero; Carolina López-Rojas; Fabien Mantilla-Sylvain; Rubén Darío Mantilla-Hernández; Alejandra de-la-Torre
Journal:  Clin Ophthalmol       Date:  2021-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.